← Back to Search

Procedure

Stealth-Guided EVD Placement for Intracranial Hypertension

N/A
Recruiting
Led By Azam Ahmed, MD
Research Sponsored by University of Wisconsin, Madison
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age ≥ 18 years and ≤ 88 years
Be older than 18 years old
Must not have
Patients ≤ 18 and ≥ 88 years of age
Subjects who decline participation into the study
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 12 months
Awards & highlights
No Placebo-Only Group

Summary

This trial compares traditional freehand placement of brain catheters with a new method using the AxiEM Stealth image guidance system. The goal is to see if using detailed images from CT or MRI scans can help doctors place the catheters more accurately and safely in patients with conditions like hydrocephalus or brain trauma.

Who is the study for?
This trial is for adults aged 18 to 88 needing an external ventricular drain (EVD) placed, as decided by their doctor. They must be able to give consent or have a family member who can, and have a Stealth-compatible head CT or MRI. It's not for minors, prisoners, those at high medical risk as determined by the physician, emergency EVD placements without standard consent, pregnant women, or non-English speakers.
What is being tested?
The study compares traditional freehand placement of EVDs at the bedside with AxiEM Stealth image guidance—a method that uses patient-specific facial and scalp anatomy registered to CT or MRI images—to see if it improves accuracy and reduces complications.
What are the potential side effects?
While specific side effects are not listed for this procedure-based trial, potential risks may include discomfort at the insertion site, infection risk from catheter placement, possible damage to surrounding brain tissue during insertion and inaccurate placement leading to ineffective drainage.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 88 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am between 18 and 88 years old.
Select...
I do not wish to participate in the study.
Select...
I had an emergency procedure to drain fluid from my brain.
Select...
I or my legal representative can give consent.
Select...
I do not speak English.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Accuracy of catheter tip compared to foramen of Monro
Catheter device
Secondary study objectives
Durability of EVD
Infection rate
New neurological deficits
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Axium Stealth Image GuidanceExperimental Treatment2 Interventions
The novelty of this study is to investigate whether using image guidance technology can improve EVD catheter placement. Image guidance is used very commonly for EVD and shunt placement in the operating room with excellent accuracy and precision. We hypothesize that using this same workflow at the bedside will improve accuracy; decrease the number of passes needed for a successful placement, decrease the number of post-placement hemorrhagic events, and help improve the effectiveness of the catheter as well as patient outcomes.
Group II: EVD placementActive Control1 Intervention
Catheter placement is most commonly performed via a freehand approach using external anatomical landmarks to help identify the location of the lateral ventricle within the brain without the aid of imaging. Proper identification of the ventricles on pre-procedure imaging, surgeon skill, and estimation of pathologic perturbations to the normal location of the ventricles all factor into the success of catheter placement. Multiple passes are often required. The accuracy rate from the freehand technique has been reported to range from 40 to 98 percent.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
The AxiEM Stealth image guidance system enhances the accuracy of External Ventricular Drain (EVD) placement by using CT or MRI scans registered to the patient's facial and scalp anatomy. This method allows for precise localization of the lateral ventricles, reducing the risk of complications such as catheter misplacement, occlusion, or damage to brain structures. Accurate EVD placement is crucial for effective cerebrospinal fluid drainage and minimizing patient morbidity, especially in cases where traditional freehand techniques may be less reliable due to altered intracranial anatomy from trauma or pathology.
From Safety to Benefit in Cell Delivery During Surgical Repair of Ebstein Anomaly: Initial Results.Future Perspectives in Percutaneous Treatment of Tricuspid Regurgitation.Overview of Optimal Techniques for Pericardiocentesis in Contemporary Practice.

Find a Location

Who is running the clinical trial?

University of Wisconsin, MadisonLead Sponsor
1,237 Previous Clinical Trials
3,200,925 Total Patients Enrolled
Azam Ahmed, MDPrincipal InvestigatorUniversity of Wisconsin, Madison
1 Previous Clinical Trials
11 Total Patients Enrolled

Media Library

EVD placement (Procedure) Clinical Trial Eligibility Overview. Trial Name: NCT03696043 — N/A
External Ventricular Drain Research Study Groups: EVD placement, Axium Stealth Image Guidance
External Ventricular Drain Clinical Trial 2023: EVD placement Highlights & Side Effects. Trial Name: NCT03696043 — N/A
EVD placement (Procedure) 2023 Treatment Timeline for Medical Study. Trial Name: NCT03696043 — N/A
~13 spots leftby Dec 2025